ARID3a expression in human hematopoietic stem cells is associated with distinct gene patterns in aged individuals

Area of Science:

• Immunology
• Hematopoiesis
• Aging Research

Background:

• Immunologic aging causes immune dysfunction, reducing elderly quality of life.
• Defects in early hematopoiesis contribute to reduced lymphoid cells and impaired immunity in the elderly.
• The role of DNA-binding protein ARID3a in aging-related immune changes is unclear.

Purpose of the Study:

• To investigate the role of ARID3a in hematopoietic stem cells (HSCs) concerning age-related immune decline.
• To determine if ARID3a expression levels change with age and impact immune cell development.

Main Methods:

• Compared ARID3a expression in HSCs from young and aged healthy individuals.
• Inhibited ARID3a in young HSCs to assess its effect on B cell development.
• Increased ARID3a levels in aged HSCs in vitro to observe changes in B cell maturation.
• Performed single-cell analyses to identify gene expression differences.

Main Results:

• Decreased frequencies of ARID3a-expressing HSCs were observed in aged individuals.
• ARID3a inhibition in young HSCs limited B cell potential.
• Modulating ARID3a levels in aged HSCs affected B cell development and maturation.
• Identified differentially expressed genes in aged versus young ARID3a-expressing HSCs.

Conclusions:

• ARID3a-expressing HSCs from aged individuals exhibit molecular and functional differences compared to those from young individuals.
• Decreased ARID3a may contribute to age-related immune dysfunction, particularly in B lymphopoiesis.